Vertex Pharmaceuticals Incorporated shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $145M | 312k | 465.08 |
| 2024-06-30 | $45M | 96k | 468.72 |
| 2024-03-31 | $135M | 323k | 418.01 |
| 2023-12-31 | $121M | 296k | 406.89 |
| 2023-09-30 | $70M | 202k | 347.74 |
| 2023-06-30 | $135M | 385k | 351.91 |
| 2023-03-31 | $195M | 619k | 315.07 |
| 2022-12-31 | $213M | 739k | 288.78 |
| 2022-09-30 | $192M | 662k | 289.54 |
| 2022-06-30 | $145M | 516k | 281.79 |
| 2022-03-31 | $211M | 809k | 260.97 |
| 2021-12-31 | $71M | 322k | 219.60 |
| 2021-09-30 | $13M | 70k | 181.39 |
| 2021-06-30 | $48M | 236k | 201.63 |
| 2021-03-31 | $59M | 274k | 214.89 |
| 2020-12-31 | $141M | 598k | 236.34 |
| 2020-09-30 | $34M | 124k | 272.12 |
| 2020-06-30 | $37M | 126k | 290.31 |
| 2020-03-31 | $183M | 768k | 237.95 |
| 2019-12-31 | $59M | 269k | 218.95 |
| 2019-09-30 | $4.8M | 29k | 169.42 |
| 2019-06-30 | $1.7M | 9.3k | 183.39 |
| 2019-03-31 | $13M | 69k | 183.94 |
| 2018-12-31 | $64M | 384k | 165.71 |
| 2018-09-30 | $37M | 191k | 192.74 |
| 2018-06-30 | $62M | 365k | 169.96 |
| 2018-03-31 | $25M | 152k | 162.98 |
| 2017-12-31 | $24M | 159k | 149.86 |
| 2017-09-30 | $136M | 893k | 152.04 |
| 2017-06-30 | $1.2M | 9.4k | 128.86 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated